Form 8-K - Current report:
SEC Accession No. 0001104659-26-012081
Filing Date
2026-02-09
Accepted
2026-02-09 16:19:28
Documents
13
Period of Report
2026-02-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm265633d1_8k.htm   iXBRL 8-K 32588
2 EXHIBIT 99.1 tm265633d1_ex99-1.htm EX-99.1 10373
  Complete submission text file 0001104659-26-012081.txt   214703

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wrby-20260204.xsd EX-101.SCH 3023
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wrby-20260204_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wrby-20260204_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT tm265633d1_8k_htm.xml XML 3211
Mailing Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013
Business Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013 (646) 847-7215
Warby Parker Inc. (Filer) CIK: 0001504776 (see all company filings)

EIN.: 800423634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40825 | Film No.: 26611689
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)